Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

H7N9: A Novel Influenza Virus and it’s Control

Published: Thursday, May 09, 2013
Last Updated: Thursday, May 09, 2013
Bookmark and Share
Whilst the virus remains as one primarily circulating in birds, breaking this cycle of replication is the only effective response to its control.

Poultry markets in Shanghai and other affected areas have been closed, reducing the mixing of birds and human-bird contact. Once infected flocks are identified the OIE (Word Organisation for Animal Health) recommends culling as the first action to prevent further transmission. However, whilst the virus is present in free-flying domesticated and wild birds this may not be fully effective and vaccination may need to be considered.

Vaccination against influenza is widely practised in people, in the form of the seasonal 'flu jab', and had been used by China and other countries to control influenza in poultry. A significant difficulty with this approach is that conventional vaccines take several months to produce in usable quantity and are highly tailored to the virus they are used to control. Mutational changes in the virus may enable it to continue to replicate and spread.

Work is underway at The Pirbright Institute to produce vaccines that can be grown more quickly and provide a much broader range, and more long lasting, protection than presently achievable. Collaborations with Oxford University and Imperial College London aim to demonstrate efficacy in other species, including humans. One vaccine recently developed at the Institute is presently being tested for its ability to protect against H7N9.

In other work at the Institute we are identifying genetic lines of chicken that are naturally resistant to influenza infection and are also developing tests that can give a rapid read-out of an animal's infection status without having to take samples back to the laboratory. Rapid diagnosis in the field is particularly important as H7N9, unlike H5N1, is clinically silent: infected birds appear normal and well. Taken in combination these projects will provide a significant advance in the ability to control influenza in all species.

Work on these projects is funded by the Biotechnology and Biosciences Research Council (BBSRC) and the EU. UK collaborations continue with The National Institute for Medical Research, The Animal Health and Veterinary Laboratories Agency (AHVLA), Oxford and Cambridge Universities and Imperial College. International collaborations include those with several influenza laboratories in China, the US and EU.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Way to Improve Antibiotic Production
A discovery has been made which could make it easier to scale up antibiotic production for commercialisation.
Tuesday, June 18, 2013
BBSRC is Major Partner in Europe-wide Synthetic Biology Funding
BBSRC is contributing €3M as a major partner in a new call for research projects in Synthetic Biology.
Tuesday, May 14, 2013
BBSRC Supports Call for Multi-Disciplinary Research Centres in Synthetic Biology
Up to six centres will be funded in two phases; three in this financial year and three next financial year.
Friday, May 03, 2013
Vaccine Production in Plants Nets Scientist Innovator of the Year 2012
Innovation could allow quicker vaccine development to combat pandemics.
Friday, March 30, 2012
Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!